Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug repositioning
Biotech
Ignota buys Kronos' pipeline to rescue shelved programs
Ignota has bagged more drugs for its rehabilitation scheme, snapping up Kronos' pipeline months after setbacks drove the biotech off public markets.
Nick Paul Taylor
Oct 6, 2025 5:45am
Mayo Clinic helps tech-enabled R&D shop nference to $60M B round
Jan 8, 2020 8:11am
Healx raises $56M to launch 40 rare disease R&D programs
Oct 16, 2019 3:00am
Healx reels in $10M in series A funding for work on rare diseases
Jul 27, 2018 11:17am
BTI files for $69M IPO to run trials in Alzheimer's and cancer
Feb 13, 2018 8:39am
Roivant bags AstraZeneca drug in latest bid
Oct 20, 2017 8:53am
